Navigation Links
Scientists find way to target cells resistant to chemo
Date:4/24/2014

Scientists from The University of Manchester have identified a way to sensitise cancer cells to chemotherapy - making them more open to treatment.

The study published today in Cell Reports, could pave the way for the development of drugs to target cells that have become resistant to treatment.

The research team made the discovery whilst exploring the possible mechanisms behind resistance to chemotherapy drugs like Paclitaxel, often used to treat breast and colon cancer.

Dr Andrew Gilmore, who led the research team at The University of Manchester, is part of both the Wellcome Trust Centre for Cell-Matrix Research and also the Manchester Cancer Research Centre.

He said: "Cells replicate and divide through a process known as mitosis. This process is carefully controlled and if any mistake is made during normal division then the cell undergoes apoptosis otherwise known as controlled cell death.

"Failure of cells to complete mitosis correctly can be the start of cancer. We wanted to understand how this failure delay of cell division - activates apoptosis, and why some cancer cells may be able to avoid being killed."

Cancer cells replicate rapidly, and chemotherapy drugs such as paclitaxel target mitosis as a way to kill these quickly dividing cells. But cancer cells can develop resistance to the drugs.

The researchers found a particular protein known as 'Bid' in colon cancer cells, and looked at what happened when Bid was switched on.

Their results show that Bid is turned on as cells prepare to divide. This primes the cells to die if cell division takes too long. Cancer cells that were resistant to chemotherapy still turned Bid on, but went through mitosis too quickly for it to kill the cell. However, these resistant cells could be made to die by directly targeting the part of the cell where Bid works.

"Our findings demonstrate that Bid plays a central role in mitosis-relat
'/>"/>

Contact: Kath Paddison
kath.paddison@manchester.ac.uk
01-612-755-2111
University of Manchester
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Scientists identify cancer specific cell for potential treatment of gastric cancer
2. Scientists pinpoint protein that could improve small cell lung cancer therapies
3. AMP publishes curriculum recommendations for medical laboratory scientists
4. Scientists alter fat metabolism in animals to prevent most common type of heart disease
5. Scientists discover a new way to enhance nerve growth following injury
6. Scientists find key steps linking dietary fats and colon cancer tumor growth
7. Stanford scientists identify source of most cases of invasive bladder cancer
8. Scientists discover brains anti-distraction system
9. Scientists find new way to fight malaria drug resistance
10. Stanford scientists develop playbook for reverse engineering tissue
11. Scientists unlock secrets of protein produced by disease-causing fungus
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... Hershey, Pa. (PRWEB) May 22, 2015 ... has been selected to participate in the 2015 Congress ... event is described as a gathering of “America’s highest ... about new areas of healthcare, set new goals and ... will include a live surgery, during which we can ...
(Date:5/22/2015)... NY (PRWEB) May 22, 2015 Hands ... that June 17, 2015, the Annual One Day Sale ... Since 2007, Hands On HCMT offers drastically reduced certificates one ... and estheticians have enough sessions, through what used to be ... is wonderful for the community as well. This once a ...
(Date:5/22/2015)... May 22, 2015 Family, friends, students, ... world-renowned surgical oncologist, Dr. LaSalle D. Leffall, on Monday, ... luncheon began after Grand Rounds in the hospital’s Tower ... anxiously outside the auditorium, trying to keep the secret. ... if he sees me, he’ll know something is up,” ...
(Date:5/22/2015)... May 22, 2015 Coordinating care ... difficult process. Historically providers have not been reimbursed ... Starting in 2015, Medicare has paved the way ... Thanks to the launch of Oculus Health ... health systems using the platform will now be ...
(Date:5/22/2015)... According to a new Aegis Living Study ... as likely to worry about what will happen to their ... Boomers, 69% Silent Generation), which may help explain why nearly ... aging, particularly Millennials (47%), Gen X’ers (51%), and Boomers (43%). ... 2015 among more than 2,000 U.S. adults ages 18+. ...
Breaking Medicine News(10 mins):Health News:Milton Hershey School Student Chosen for Congress of Future Medical Leaders 2Health News:Hands On HealthCare Massage Therapy & Wellness Day Spa Announces Their Eighth Annual One Day Sale on Gift Certificates Will Take Place on June 17, 2015 2Health News:Hands On HealthCare Massage Therapy & Wellness Day Spa Announces Their Eighth Annual One Day Sale on Gift Certificates Will Take Place on June 17, 2015 3Health News:Colleagues Surprise Dr. LaSalle Leffall with 85th Birthday Celebration 2Health News:Oculus Health Care Coordination Platform Officially Launched 2Health News:Oculus Health Care Coordination Platform Officially Launched 3Health News:Oculus Health Care Coordination Platform Officially Launched 4Health News:New Study Reveals America’s Fear of Aging 2Health News:New Study Reveals America’s Fear of Aging 3
... ... Today, Is Released to More Distributors in Pennsylvania. LeadConfirm Professional, the first and only ... more doctors and health care professionals in Kansas through a wider distribution base. ... San Diego, CA ...
... PORTLAND, Ore., June 3 Dr. Mark E. Schafer, ... internationally recognized expert in ultrasonic technology, recently presented a ... Meeting of the Acoustical Society of America in Portland, ... intensity focused ultrasound, or HIFU, has driven the need ...
... China, June 2 /PRNewswire-Asia-FirstCall/ -- China Sky One Medical,Inc. ... CSKI ), a leading,fully integrated pharmaceutical company producing ... announced that it obtained,approval from the State Food and ... Sodium eye drops. The document number for the drug ...
... 2 Speaker Nancy Pelosi held a press availability with ... in the Capitol this afternoon. Below are their remarks: ... privilege to welcome the Secretary to the Speaker,s office. Both of ... we,ve had - of course the Secretary went there long after ...
... Andy" Holder Visits Kaheka Pharmacy To Inspire Others to Manage Chronic ... of an inspirational nationwide tour, "Iron Andy" Holder, an Ironman competitor ... in a Wellness Fair at a Don Quijote Pharmacy in Honolulu ... 14-year-old boy with type 1 diabetes, who was inspired by Andy,s ...
... , ORANGE COUNTY, Calif., June 2 Beckman Coulter, Inc. ... marketer of products that simplify, automate, and innovate complex biomedical ... , , (Logo: http://www.newscom.com/cgi-bin/prnh/20031202/BECLOGO ) , ... 24, 2009, Chicago, Illinois - The American Association for, ...
Cached Medicine News:Health News:Parents In Kansas Can Now Test Their Children For Lead Exposure Using Saliva 2Health News:Parents In Kansas Can Now Test Their Children For Lead Exposure Using Saliva 3Health News:Parents In Kansas Can Now Test Their Children For Lead Exposure Using Saliva 4Health News:Sound Surgical Technologies' Chief Technology Officer Presents Paper on Focused Ultrasound Technology 2Health News:China Sky One Medical, Inc. Obtains SFDA Approval for Diclofenac Sodium Eye Drops 2Health News:China Sky One Medical, Inc. Obtains SFDA Approval for Diclofenac Sodium Eye Drops 3Health News:Pelosi Remarks Before Meeting with Secretary of Health and Human Services Kathleen Sebelius 2Health News:Ironman Competitor with Diabetes Inspires Individuals with Diabetes to Live Without Limits 2Health News:Upcoming Investor Events at The American Association for Clinical Chemistry (AACC) Annual Meeting & Clinical Lab Exposition 2
(Date:5/21/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/6csvbs/market_assessment ... "Market Assessment of Respiratory Diagnostics in the United ... ,     (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ,This research service provides ... in the United States ... provides detailed analysis of the current and forecasted ...
(Date:5/21/2015)... REDWOOD CITY, Calif. , May 21, 2015  Cardica, ... 20, 2015, new employee Greg Watson , the company,s ... 400,000 shares of the company,s common stock, at a per ... May 20, 2015. The stock option was granted pursuant to ... board of directors in May 2015 under Rule 5653(c)(4) of ...
(Date:5/21/2015)... YORK , 21. Mai 2015 ... DPRX ), ein Unternehmen für ... auf die Entwicklung und Vermarktung von ... konzentriert, kündigte heute eine wissenschaftliche Posterpräsentation ... Phase-III-Zulassungsstudie des Unternehmens vorstellt, OneStep-1 und ...
Breaking Medicine Technology:United States and Europe Respiratory Diagnostics Market Assessment 2015 2Cardica Announces New Employment Inducement Grant 2Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 2Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 3Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 4Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 5Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 6Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 7
... Direct Factor Xa Inhibitor,Shows a Significant Reduction ... with Enoxaparin with Similarly Low Bleeding,Rates , ... III clinical trial,data presented today at the ... Congress demonstrate that once-daily,rivaroxaban (Xarelto®) achieved superior ...
... Insmed Inc. (NASDAQ:INSM), a ,biopharmaceutical company focused on the ... metabolic diseases with unmet,medical needs, today announced that ... Emerging Growth,Opportunities Conference in New York City. ... Mandarin Oriental Hotel in New,York City, will run ...
Cached Medicine Technology:Phase III Trial Results Show Superiority of Rivaroxaban over,Enoxaparin for the Prevention of Venous Thromboembolism in Patients,Undergoing Knee Replacement Surgery 2Phase III Trial Results Show Superiority of Rivaroxaban over,Enoxaparin for the Prevention of Venous Thromboembolism in Patients,Undergoing Knee Replacement Surgery 3Phase III Trial Results Show Superiority of Rivaroxaban over,Enoxaparin for the Prevention of Venous Thromboembolism in Patients,Undergoing Knee Replacement Surgery 4Phase III Trial Results Show Superiority of Rivaroxaban over,Enoxaparin for the Prevention of Venous Thromboembolism in Patients,Undergoing Knee Replacement Surgery 5Insmed Inc. to Present at C.E. Unterberg, Towbin Growth Conference 2
An injectable IOL, single-use injector for the IOL and post-op protective eye-shield all packaged in one handy, ready-to-use system pack....
... IOL is the newest advance in lens ... patient and surgeon in mind. Its unique ... crosslinked with PMMA haptics to provide superb ... performance and biocompatibility. The high memory lathe-cut ...
Raysoft Foldable Intraocular Lens....
BIGBAG Hydrophilic Acrylic Lens for high myopia....
Medicine Products: